Liching cao

Company: Sangamo Therapeutics

Job title: Director - Bioanalytical Operations

Seminars:

Clinical Enrolment Assay to Detect Pre-existing Neutralizing Antibodies to AAV6 With Demonstrated Transgene Expression in Gene Therapy Trials 9:00 am

Clinical enrollment cut off determination for pre-screening patients supporting AAV6 gene therapy trials Does assay format matter? NAb or TAb approach for clinical trial eligibility criteria Explore AAV6 seroprevalence evaluationsRead more

day: Day Two